跳至主要内容
临床试验/EUCTR2014-001948-37-GB
EUCTR2014-001948-37-GB进行中(未招募)1 期

Intramuscular oxytocics: A multi-centre randomised comparison study of intramuscular Carbetocin, Syntocinon and Syntometrine for the third stage of labour following vaginal birth - IMox study

orth Bristol NHS Trust0 个研究点目标入组 6,285 人开始时间: 2014年9月30日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
6,285

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • - 18 years of age, or older, at time of delivery
  • - Singleton pregnancy
  • - Vaginal birth (spontaneous and instrumental)
  • - Any gestation
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 6285
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • - Significant antepartum haemorrhage (>50ml) or suspected or proven placenta abruption
  • - Maternal coagulation disorder
  • - Multiple pregnancy (twins or higher order)
  • - Intrauterine fetal death
  • - Patients who would decline blood products if required (ie: Jehovah's Witnesses - clinicians may have a lower threshold for administering additional prophylactic uterotonic drugs to these patients)
  • - Known or suspected hypertensive disorders, including pre-eclampsia, pregnancy induced hypertension, essential hypertension (even if blood pressure well controlled), and patients with hypertension in labour
  • - Patients with peripheral, hepatic or cardiac disease
  • - Patients with an allergy or hypersensitivity to any of the active ingredients in Carbetocin, Syntometrine or Syntocinon

研究者

发起方
orth Bristol NHS Trust

相似试验